- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.08. | Vaso Corporation Announces Financial Results for Second Quarter of 2026 | 405 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading MedTech company with a business portfolio in professional sales services and proprietary non-invasive... ► Artikel lesen | |
| 03.08. | Vaso Corporation Completes Sale of NetWolves Network Services to COEO Solutions | 285 | GlobeNewswire (Europe) | Vaso Corporation137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 Investor Contact:Jonathan NewtonInvestor RelationsPhone: 516-997-4600Email: jnewton@vasocorporation.com... ► Artikel lesen | |
| 31.07. | VASO Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 23.07. | Vaso Corporation beruft Shaun McMeans in den Verwaltungsrat | 1 | Investing.com Deutsch | ||
| VASO Aktie jetzt für 0€ handeln | |||||
| 23.07. | Vaso appoints Shaun McMeans to board of directors | 1 | Investing.com | ||
| 23.07. | Vaso Corporation Appoints Shaun McMeans to Board of Directors | 208 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., July 23, 2026 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and IT services, professional... ► Artikel lesen | |
| 23.07. | VASO Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 30.06. | VASO Global Raises Over £5M in Venture, Grant, and Debt Funding Round | 1 | FinSMEs | ||
| 30.06. | VASO Global wins support for recycled glass panels | 1 | The Construction Index | ||
| 15.05. | Vaso Corporation Announces Financial Results for First Quarter of 2026 | 436 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., May 15, 2026 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and IT services, professional... ► Artikel lesen | |
| 08.05. | VASO Corp - 8-K, Current Report | - | SEC Filings | ||
| 31.03. | Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2025 | 239 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., March 31, 2026 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and IT services, professional... ► Artikel lesen | |
| 17.12.25 | Vaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCare | 462 | GlobeNewswire (Europe) | Vaso Corporation137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 Investor Contact:Jonathan NewtonInvestor RelationsPhone: 516-997-4600 Email: jnewton@vasocorporation.com... ► Artikel lesen | |
| 19.11.25 | NANO-X IMAGING LTD: Nanox Reaches Agreement with Vaso Corporation to Acquire VasoHealthcare IT, Accelerating U.S. Rollout of AI Solutions | 604 | GlobeNewswire (Europe) | PETACH TIKVA, Israel, Nov. 19, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that the parties... ► Artikel lesen | |
| 14.11.25 | Vaso Corporation Announces Financial Results for Third Quarter of 2025 | 386 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRAZENECA | 142,60 | +0,71 % | Novo Nordisk zahlt bis zu 2,6 Milliarden Dollar für Biotech - warum Eli Lilly, GSK und AstraZeneca ebenfalls Milliarden auf neue Technologien setzen | ||
| EYEPOINT | 3,060 | -1,29 % | XFRA PV3B: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 40,640 | +5,26 % | Genentech, Ionis Reveal Positive Interim Data From Phase III Sefaxersen Study In IgA Nephropathy | SOUTH SAN FRANCISCO (dpa-AFX) - Genentech, affiliated to Swiss drug major Roche Holding AG (RHHBY, RO.SW, ROG.SW), and partner Ionis Pharmaceuticals, Inc. (IONS) announced Wednesday positive... ► Artikel lesen | |
| CSPC PHARMA | 1,016 | -3,90 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - DATA FROM PHASE I CLINICAL STUDY OF SYS6002 AS MONOTHERAPY FOR THE TREATMENT OF ADVANCED CERVICAL CANCER ... | ||
| SELLAS LIFE SCIENCES | 10,400 | +3,48 % | SELLAS Life Sciences Group Inc mit PAUKENSCHLAG: Folgt jetzt der nächste Kursrutsch? - Unbedingt noch vor Börsenschluss lesen! | ||
| MADRIGAL PHARMACEUTICALS | 425,00 | -0,02 % | Madrigal: Rezdiffra zeigt in MASH-Studie konsistente Wirksamkeit über genetische Varianten hinweg | ||
| ACADIA PHARMACEUTICALS | 17,620 | +0,92 % | RBC Capital bestätigt Einstufung für Acadia Pharmaceuticals nach Patent-Entwicklungen | ||
| CATALYST PHARMACEUTICALS | 27,300 | +2,63 % | Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals | The Italian pharma company grows its presence in the U.S. market and strengthens its global leadership in Brain Health and Rare DiseasesCompletion of the transaction gives Angelini Pharma ownership... ► Artikel lesen | |
| OPUS GENETICS | 4,200 | +5,53 % | Could an FDA Nod for MR-141 Give Viatris (VTRS) and Opus Genetics (IRD) a Presbyopia Payoff? | ||
| CHUGAI PHARMACEUTICAL | 34,630 | +1,49 % | Chugai Pharmaceutical Co., Ltd.: Drei Chugai-Forscher, die hinter der Entdeckung von Hemlibra zur Behandlung von Hämophilie A stehen, erhalten renommierten US-amerikanischen Lasker Award, eine der weltweit angesehensten wissenschaftlichen Ehrungen | Anerkennung für die Erfindung eines bispezifischen Antikörpers, der das Behandlungsparadigma mit einem unkonventionellen Ansatz transformiert hat
Anerkennung für die Realisierung eines neuartigen... ► Artikel lesen | |
| SAVARA | 4,439 | +2,95 % | Citizens reiterates Savara stock rating on Molbreevi launch outlook | ||
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2027 Ended June 30, 2026 and Provides Conference Call Information | Northvale, New Jersey--(Newsfile Corp. - August 13, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products... ► Artikel lesen | |
| GALECTIN THERAPEUTICS | 3,200 | +0,63 % | Galectin Therapeutics Inc.: Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026 | ||
| BIODEXA PHARMACEUTICALS | 0,461 | -11,97 % | Biodexa Pharmaceuticals Plc - 6-K, Report of foreign issuer | ||
| NEURIZON THERAPEUTICS | 0,048 | 0,00 % | NEURIZON THERAPEUTICS LIMITED: Updated Investor Presentation and Webinar Reminder |
VASO CORPORATION gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VASO CORPORATION finden Sie auf Wallstreet Online.